New!   E-Learning:  Link to patient setup tutorial
Installation and signal quality
Applications and Clinical benefits

The new reference in Cardiac Output monitoring

HOME

• Why Cardiac Output ?
• SM-ICG Technology
• Products
• In use
• F.A.Q
• Innovations

• Clinical benefits
• Clinical studies
• Case studies
• References

• Project's origin
• Ethical standards
• Sales representatives
• Contact
• Certificates

• A breakthtough clinical study
• European Respiratory Society, Vienna
• European College of Sports Sciences, Glasgow

• Facebook
• Linkedin
• Twitter

   Sitemap

Clinical benefits

NON-INVASIVE

• Fewer constraints:
  • Complete safety for the patient
  • No risk of infection or injury
  • Saves time for patient care
• More flexibility:
  • Extensive applications (measurements at rest and during exercise)
  • Snapshots or continuous monitoring
  • Can be used routinely by nurses and/or technicians

RELIABLE

• Validations:
  • Unmatched reproducibility and sensitivity
  • Good agreement with reference methods at rest (incl. severely ill patients) and during exercise
  • Proven clinical value even in difficult patients and challenging measurement conditions
• High quality standards:
  • Excellence in manufacturing and customer service
  • ISO 13485 standard
  • Market approvals in the USA (FDA), Europe, Japan, among other.

EASY TO USE

• MS-Windows™ based software:
  • User friendly, short learning curve
  • Works in every application
  • Detailed printed report and data export to text and MS-Excel™ files
• Easy to handle hardware:
  • Few connections or wireless
  • Transportable or handheld
  • No maintenance

COST EFFECTIVE

• Economical day-to-day use:
  • Disposables: 6 electrodes per patient only
  • Low cost compared to invasive or other noninvasive technologies
  • Saves valuable time for operators
• An attractive business model:
  • No indirect costs (catheter complications)
  • May improve patient outcome
  • Potential direct or indirect revenue generator

UNIQUE FEATURES

• Potentially more efficient than other invasive or noninvasive hemodynamic systems thanks to similar accuracy, but better reproducibility and sensitivity.
• Offers a combination of parameters that enables accurate evaluation of any hemodynamic condition. For instance: fluid status and optimization can be efficiently assessed and guided.
• Features displays that enable a quick and efficient evaluation of the patient's hemodynamic equilibrium: the Hemodynamic Cross.

  

• The analysis of signal abnormalities is potentially extremely useful for the early diagnosis of severe pathologies when they are still reversible.

  

  • Double S peak: Left and right ventricle dyssynchrony
  • Elevated O wave: Fluid overload as a consequence of Congestive Heart Failure
  • Elevated P wave: Ventricular stiffness

The combination of the low cost and ease of use, reduced limitations, zero risk and high performance make PhysioFlow^® the technology of choice to finally establish noninvasive hemodynamic diagnosis and monitoring as a standard of care.